> Participants 2010
Representatives from industry, technology transfer and academia:
- Affectis Pharmaceuticals AG
- AmVac AG
- Anatomie UK Essen
- Aranca UK
- Ascenion GmbH
- aws
- Bayer Schering Pharma AG
- Bayerische Patentallianz GmbH
- Bayerisches Staatsministerium für Wirtschaft, Infrastruktur, Verkehr und Technologie
- BayTech Venture Capital
- Bergen Teknologioverføring AS
- BioCentiv GmbH
- BioM Biotech Cluster Development GmbH
- Bionamics GmbH
- Birkeland Innovasjon
- Boehringer Ingelheim Pharma GmbH & Co. KG
- BUKO Pharma-Kampagne/med4all
- CAST GmbH
- CeMM- Research Center for Molecular Medicine
- Charité Universitätsmedizin
- DAIICHI SANKYO EUROPE GmbH
- Department of Traumatology Ludwig Maximilins University Munich
- Dr. von Hauner Children´s Hospital
- DRFZ
- DUALIS MedTech GmbH
- EMBLEM Technology Transfer GmbH
- EPO
- ethris GmbH
- Eurasanté
- European Tech Transfer Summit
- FIST S.A.
- Fondazione IRCCS Ca´ Granda Ospedale Maggiore Policlinico
- Fraunhofer Institute for Cell Therapy and immunology
- Fraunhofer IZI
- Fraunhofer IZM
- Fraunhofer-Gesellschaft
- Genzyme Corporation
- German Cancer Research Center (DKFZ)
- Gimv
- GlaxoSmithKline GmbH & Co. KG
- Grünenthal GmbH
- Hannover Medical School
- Heinrich-Heine-Universität
- Helmholtz-Gemeinschaft
- Helmholtz Zentrum München
- Hertin Anwaltssozietät
- High-Tech Gründerfonds
- HZI, Dep. for Vaccinology and Applied Microbiology
- IGBMC
- Innovative Health Diagnostics
- Institut für Umweltmedizinische Forschung
- Institut Pasteur
- IP Bewertungs AG (IPB)
- ipal GmbH
- iThera Medical GmbH
- Jagiellonian University
- Jochum Langner Konsultation
- King´s College London (UK)
- Klinik f. Gastroenterologie
- KONOCOM
- Lead Discovery Center GmbH
- Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V.
- Life Science Inkubator GmbH
- Life Sciences Partners
- Life Science Stiftung
- LSP
- Ludwig Maximilians Universität
- Maiwald Patentanwalts GmbH
- Max Delbruck Center for Molecular Medicine
- Max-Planck-Innovation GmbH
- Medizinische Universität Wien
- MedTRACK
- Merck Serono GmbH
- MLawGroup
- MSD SHARP & DOHME GMBH
- Neurology, Justus-Liebig-University
- NGFN Geschäftsstelle c/o Deutsches Krebsforschungszentrum – DKFZ
- Novo Nordisk A/S
- Osborne Clarke
- Patent Attorneys
- Peter Kayatz
- Project Management Jülich
- Protagen AG
- PROvendis GmbH
- R&D-Biopharmaceuticals
- RWTH Aachen University
- Shire Pharmaceuticals
- SpectraMab
- Staatz Business Development & Stretegy
- SuppreMol GmbH
- Technical University of Munich
- TEVA Deutschland GmbH
- TVM Capital GmbH
- UMR 975- CRICM
- University Hospital Heidelberg, Molecular Virology
- University of Cologne/ Medical Microbiology
- University of Milan- Unimitt
- University of Oslo
- University of Regensburg
- University of Würzburg
- Vesalius Biocapital
- Vibrac Laboratories
- Vossius & Partner, Patentanwälte
- Wyeth Pharma GmbH
BioVaria brings together international business developers and licensing scouts with the nation’s top inventors from public biopharmaceutical research.